Delivery Order SPE2DR25D3102-SPE2DR26F2P2Z
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 25, 2025, for the supply of Gvoke HypoPen 2-pack auto-injectors (1 mg/0.2 mL dosage). This is a firm fixed-price delivery order with a ceiling value of $10,843.19 and an ultimate completion date of August 26, 2025. The award was competitively procured with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and...
- The Defense Logistics Agency awarded a delivery order valued at $2,066.98 to AmerisourceBergen Drug Corp on December 3, 2025, for the supply of Gvoke Hypoepen 2-packs (0.5mg/0.1mL auto-injectors). The award was made on a firm fixed-price basis with no set-aside designation, indicating competitive procurement. The contract is scheduled for completion by December 4, 2025, with performance at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is...
- The Defense Logistics Agency awarded a $1,734.47 firm fixed price delivery order to AmerisourceBergen Drug Corp on September 9, 2025, for the supply of Gvoke HypoPen auto-injectors (1 mg/0.2 ml, 2-pack). The contract, which represents a non-competitive delivery order under an existing indefinite delivery vehicle, will be fulfilled from the vendor's Conshohocken, Pennsylvania location with a completion date of September 10, 2025. This award is a child contract issued under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Gvoke HypoPen 1-mg/0.2-ml auto-injector pens with a ceiling value of $1,057.60 under a firm fixed price contract type. The award was made on November 7, 2025, with an ultimate completion date of November 10, 2025. This is a non-set-aside competitively awarded order, and the place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Gvoke HypoePen, a 2-pack auto-injector medication (1 mg/0.2 mL) with a ceiling value of $1,505.56. This firm fixed-price delivery order, issued on November 25, 2025, with an ultimate completion date of November 26, 2025, represents a non-competitive award under the company's existing indefinite delivery contract vehicle. The pharmaceutical product will be delivered to Conshohocken, Pennsylvania, where...
- The Defense Logistics Agency awarded a delivery order valued at $1,240.18 to AmerisourceBergen Drug Corp for GVOKE HypoPen 2-Pack (1 mg/0.2 ml) on November 5, 2025, with completion expected by November 6, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at the vendor's Conshohocken, Pennsylvania location. GVOKE HypoPen is a glucagon auto-injector used for emergency treatment of severe hypoglycemia in patients with diabetes, making...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $11,519.71 to AmerisourceBergen Drug Corp for Gvoke HypoPen 2-Pack 1 mg/0.2 ml auto-injectors. This firm fixed-price, competitively awarded contract was executed on August 25, 2025, with an ultimate completion date of August 26, 2025. Performance will take place at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The delivery order operates as a child contract under AmerisourceBergen's existing indefinite...
- The Defense Logistics Agency awarded a delivery order valued at $4,981.46 to AmerisourceBergen Drug Corp on May 30, 2025, for the supply of Gvoke HypoPen 2-pack (1 mg/0.2 mL) auto-injectors. The contract, which is not set aside and was competitively awarded, specifies a firm fixed price structure with an ultimate completion date of June 2, 2025. Performance will be executed from the vendor's location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen Drug Corp's...
- The Defense Logistics Agency awarded a delivery order valued at $5,028.47 to AmerisourceBergen Drug Corp for the supply of Gvoke HypoPen 2-pack auto-injectors (0.5mg/0.1ml) on August 29, 2025, with an ultimate completion date of September 2, 2025. This non-competitive delivery order represents a firm fixed price transaction and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The product is a glucagon emergency injection device used for treating severe...
- The Defense Logistics Agency awarded a delivery order valued at $4,087.62 to AmerisourceBergen Drug Corp for GVOKE HypoPen 2-Pack 1 mg/0.2 ml auto-injectors. This competitively awarded, firm fixed-price contract was executed on August 11, 2025, with an ultimate completion date of August 12, 2025. The contract involves delivery to Conshohocken, Pennsylvania, where AmerisourceBergen Drug Corp maintains its corporate headquarters. No set-aside provisions were utilized for this award. This...
- SPE2DR25D3102Indefinite Delivery Contract
- SPE2DR25D3102-SPE2DR26F2P2ZDelivery Order
The Defense Logistics Agency awarded a $2,558.24 firm fixed price delivery order to AmerisourceBergen Drug Corp on December 5, 2025, for Gvoke HypoPen 1-pack 1 mg/0.2 ml auto-injectors, with an ultimate completion date of December 8, 2025. The contract carries no set-aside designation and represents a competitive award under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $1 billion through December 2026. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement across military and veteran healthcare systems. This delivery order falls within AmerisourceBergen's comprehensive pharmaceutical supply agreement with DLA, which enables the company to provide a broad range of pharmaceutical products and medical supplies to support military healthcare programs globally. Gvoke HypoPen is an emergency glucagon auto-injector used for treating severe hypoglycemia in patients with diabetes, reflecting the type of specialized medical commodities and emergency therapeutics that the company routinely supplies through its federal contracts. The relatively short completion timeline indicates this is a routine replenishment order fulfilling immediate medical supply needs for Department of Defense healthcare operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.6k | 12/4/25 |